Ali Nahvi
Yale University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ali Nahvi.
Nature | 2002
Wade C. Winkler; Ali Nahvi; Ronald R. Breaker
Although proteins fulfil most of the requirements that biology has for structural and functional components such as enzymes and receptors, RNA can also serve in these capacities. For example, RNA has sufficient structural plasticity to form ribozyme and receptor elements that exhibit considerable enzymatic power and binding specificity. Moreover, these activities can be combined to create allosteric ribozymes that are modulated by effector molecules. It has also been proposed that certain messenger RNAs might use allosteric mechanisms to mediate regulatory responses depending on specific metabolites. We report here that mRNAs encoding enzymes involved in thiamine (vitamin B1) biosynthesis in Escherichia coli can bind thiamine or its pyrophosphate derivative without the need for protein cofactors. The mRNA–effector complex adopts a distinct structure that sequesters the ribosome-binding site and leads to a reduction in gene expression. This metabolite-sensing regulatory system provides an example of a ‘riboswitch’ whose evolutionary origin might pre-date the emergence of proteins.
Nature | 2004
Wade C. Winkler; Ali Nahvi; Adam Roth; Jennifer A. Collins; Ronald R. Breaker
Most biological catalysts are made of protein; however, eight classes of natural ribozymes have been discovered that catalyse fundamental biochemical reactions. The central functions of ribozymes in modern organisms support the hypothesis that life passed through an ‘RNA world’ before the emergence of proteins and DNA. We have identified a new class of ribozymes that cleaves the messenger RNA of the glmS gene in Gram-positive bacteria. The ribozyme is activated by glucosamine-6-phosphate (GlcN6P), which is the metabolic product of the GlmS enzyme. Additional data indicate that the ribozyme serves as a metabolite-responsive genetic switch that represses the glmS gene in response to rising GlcN6P concentrations. These findings demonstrate that ribozyme switches may have functioned as metabolite sensors in primitive organisms, and further suggest that modern cells retain some of these ancient genetic control systems.
Nature Structural & Molecular Biology | 2003
Wade C. Winkler; Ali Nahvi; Narasimhan Sudarsan; Jeffrey E. Barrick; Ronald R. Breaker
Riboswitches are metabolite-binding RNA structures that serve as genetic control elements for certain messenger RNAs. These RNA switches have been identified in all three kingdoms of life and are typically responsible for the control of genes whose protein products are involved in the biosynthesis, transport or utilization of the target metabolite. Herein, we report that a highly conserved RNA domain found in bacteria serves as a riboswitch that responds to the coenzyme S-adenosylmethionine (SAM) with remarkably high affinity and specificity. SAM riboswitches undergo structural reorganization upon introduction of SAM, and these allosteric changes regulate the expression of 26 genes in Bacillus subtilis. This and related findings indicate that direct interaction between small metabolites and allosteric mRNAs is an important and widespread form of genetic regulation in bacteria.
Nature | 2015
John A. Howe; Hao Wang; Thierry O. Fischmann; Carl J. Balibar; Li Xiao; Andrew Galgoci; Juliana C. Malinverni; Todd W. Mayhood; Artjohn Villafania; Ali Nahvi; Nicholas J. Murgolo; Christopher M. Barbieri; Paul A. Mann; Donna Carr; Ellen Xia; Paul Zuck; Daniel Riley; Ronald E. Painter; Scott S. Walker; Brad Sherborne; Reynalda de Jesus; Weidong Pan; Michael A. Plotkin; Jin Wu; Diane Rindgen; John H. Cummings; Charles G. Garlisi; Rumin Zhang; Payal R. Sheth; Charles Gill
Riboswitches are non-coding RNA structures located in messenger RNAs that bind endogenous ligands, such as a specific metabolite or ion, to regulate gene expression. As such, riboswitches serve as a novel, yet largely unexploited, class of emerging drug targets. Demonstrating this potential, however, has proven difficult and is restricted to structurally similar antimetabolites and semi-synthetic analogues of their cognate ligand, thus greatly restricting the chemical space and selectivity sought for such inhibitors. Here we report the discovery and characterization of ribocil, a highly selective chemical modulator of bacterial riboflavin riboswitches, which was identified in a phenotypic screen and acts as a structurally distinct synthetic mimic of the natural ligand, flavin mononucleotide, to repress riboswitch-mediated ribB gene expression and inhibit bacterial cell growth. Our findings indicate that non-coding RNA structural elements may be more broadly targeted by synthetic small molecules than previously expected.
Archive | 2006
Ali Nahvi; Ronald R. Breaker
Riboswitches are metabolite-sensing RNA elements that are present in the noncoding portions of certain messenger RNAs. Each riboswitch carries an aptamer that is highly selective for its target metabolite and an expression platform that more direcdy interfaces with gene expression systems. In bacteria, changes in RNA structure brought about by ligand binding are harnessed to control expression by modulating mRNA transcription, translation, or RNA stability. The gene control mechanisms and ligand binding characteristics of riboswitches range from minimalist to surprisingly complex. Therefore it is likely that some riboswitches represent the simplest of ways to control genes, while others exhibit levels of sophistication that until now had only been seen with protein genetic factors
Chemistry & Biology | 2002
Ali Nahvi; Narasimhan Sudarsan; Margaret S. Ebert; Xiang Zou; Kenneth L. Brown; Ronald R. Breaker
Proceedings of the National Academy of Sciences of the United States of America | 2004
Jeffrey E. Barrick; Keith A. Corbino; Wade C. Winkler; Ali Nahvi; Maumita Mandal; Jennifer A. Collins; Mark Lee; Adam Roth; Narasimhan Sudarsan; Inbal Jona; J. Kenneth Wickiser; Ronald R. Breaker
Nucleic Acids Research | 2004
Ali Nahvi; Jeffrey E. Barrick; Ronald R. Breaker
RNA | 2006
Adam Roth; Ali Nahvi; Mark Lee; Inbal Jona; Ronald R. Breaker
Archive | 2003
Ronald R. Breaker; Ali Nahvi; Narasimhan Sudarsan; Margaret S. Ebert; Wade C. Winkler; Jeffrey E. Barrick; John K. Wickiser